TIMP1 reduces drug sensitivity in breast cancer [38,39,40] and promotes the growth of Burkitt lymphoma, colon cancer, and breast cancer cells [13,15,16,17]. This evidence concerns the gene TIMP1 and malignant colon neoplasm.